Person
Leo Petrossian
CEO of Neurolutions, a medical device company commercializing the IpsiHand Upper Extremity Rehabilitation System, the first FDA-authorized brain-computer interface device for chronic stroke rehabilitation (De Novo market authorization granted April 2021). He led the company's commercialization of the BCI-based handpiece, which translates brain signals from the uninjured hemisphere into movement of an impaired hand.
American · 1 current role
Physical AI footprint (1)
The physical AI companies Leo is connected to that DEPLOY verifies. The full record is one click away.
- CEO
NeuroLutions (now merged into Kandu, Inc.) developed the [IpsiHand](/models/ipsihand) System, the first FDA-cleared brain-computer interface device for stroke r
Current roles (1)
- NeuroLutions CEOSecondary-verified
Sources (2)
- https://www.neurolutions.com/news/neurolutions-receives-fda-de-novo-market-authorization-for-ipsihand/
- https://www.globenewswire.com/news-release/2021/04/26/2216682/0/en/Neurolutions-Receives-U-S-Food-and-Drug-Administration-De-Novo-Market-Authorization-for-IpsiHand-Upper-Extremity-Rehabilitation-System.html
Deploy Watch
Track Leo Petrossian on Deploy.
We notify you when a verified role changes, a founded-company event lands, or litigation surfaces.